Publication | Open Access
MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer
27
Citations
36
References
2016
Year
MYC gene copies, centromere status and PI3K activation may adversely impact trastuzumab treated mBC patient outcome and seem worthy validating in larger series.
| Year | Citations | |
|---|---|---|
Page 1
Page 1